- Case report
- Open Access
The first case of huge amebic intra-abdominal tumor with asymptomatic amebic colitis
© Higami et al. 2015
Received: 17 March 2015
Accepted: 3 June 2015
Published: 16 June 2015
We report a rare case of huge amebic intra-abdominal tumor with asymptomatic amebic colitis. This appears to represent the first report of amebic intra-abdominal tumor. A 31-year-old woman presented to a local doctor with only a sensation of abdominal fullness. Abdominal computed tomography (CT) showed a huge intra-abdominal tumor in the left abdominal cavity, and she was referred to our hospital. Colonofiberscopy for detailed examination showed multiple slight, discrete ulcers in the cecum. Ameboid trophozoites were identified from biopsy specimens, and asymptomatic amebic colitis was diagnosed. Oral metronidazole (MTZ) was administered at 1500 mg/day for 10 days. CT 14 days after starting MTZ showed no change in the intra-abdominal tumor, and resection of the tumor was therefore performed. Pathological examination revealed Entamoeba histolytica with engulfed erythrocytes complicated by hemorrhagic cyst. If an intra-abdominal tumor is present and colitis is observed, amebic intra-abdominal tumor should be considered among the differential diagnoses.
Infection by Entamoeba histolytica causes amebic colitis, which often presents as cramping abdominal pain and bloody diarrhea. While the majority of E. histolytica infections may be asymptomatic, approximately 10 % of amebic infections develop to invasive disease. Approximately 1 % of cases of invasive amebic disease develop extraintestinal disease through the bloodstream, affecting tissues such as the liver [1, 2], lungs [3–5], pericardium [6, 7], brain [8–10], and skin [11, 12]. Invasive E. histolytica infection may result in severe and potentially fatal illness, but no case reports appear to have described amebic intra-abdominal tumors.
Amebiasis is a parasitic infection caused by the intestinal protozoan E. histolytica. This parasite is estimated to infect about 50 million cases annually, with about 40,000–100,000 deaths each year. E. histolytica infection occurs when mature cysts are ingested, typically through fecally contaminated water or food, most frequently in the developing world. E. histolytica infections are commonly observed in travelers, recent immigrants, homosexual men, and inmate populations. Pregnant women, individuals with diabetes, immunocompromised individuals, patients infected with human immunodeficiency virus, and those receiving corticosteroids are at particular risk of fulminant disease [13–17]. In Japan, E. histolytica is classified as a category V infectious disease according to the Infectious Diseases Control Law (concerning the prevention of infections and medical care for patients with infections). Doctors diagnosing E. histolytica are required to report the case to a public health department within 7 days of diagnosis. According to the report of the National Institute of Infectious Disease, the number of cases of E. histolytica infection has been increasing annually, particularly since 2000, and this has been attributed to an increase in sexually transmitted cases. The number of E. histolytica cases was reported as 1047 cases in 2013. The major reported cities in 2013 were Tokyo, with 188 cases, and Osaka, with 106 cases. Given that registration of E. histolytica cases is obligatory in Japan, the breakdown of causes of infection was reported in 2012 as unknown in 51.9 % and sexually transmitted in 34.1 % . Because the patient had not visited an endemic area or traveled overseas, and reported no sexual contacts, the route of infection in this case was reported to the public health department as unknown.
Infection with E. histolytica is reportedly asymptomatic in approximately 90 % of cases. However, 4–10 % of initially asymptomatic individuals infected with E. histolytica develop symptomatic amebiasis over the course of the following year. E. histolytica can cause invasive intestinal and extraintestinal infections, which may occasionally result in severe and potentially fatal illness. The most common manifestation of invasive amebiasis is colitis, typically presenting as a several-week history of cramping abdominal pain, weight loss, and bloody diarrhea. Common sites of extraintestinal lesions are the liver and lungs, while rare case reports have described infection of the pericardium, brain, and skin. A search of PubMed using a combination of key words such as “Entamoeba histolytica”, “amebiasis,” and “intraabdominal tumor” through December 31, 2014 yielded no reports of amebic intra-abdominal tumor. Likewise, no mention of amebic intra-abdominal tumor was found in various reviews of E. histolytica infection [13–15, 19]. Amebic intra-abdominal tumor thus appears extremely rare.
In this case, diagnosis of the intra-abdominal tumor by imaging alone was very difficult. Differential diagnoses for intra-abdominal tumor include cystic mesothelioma, omental cyst, cystic lymphangioma, liposarcoma, and gastrointestinal stromal tumor. In these cases, surgical excision is usually indicated for diagnosis and treatment [20, 21].
Many reports have suggested that extraintestinal amebiasis spreads hematogenously [8, 22]. Shamsuzzam et al. reported that infection by thoracic amebiasis usually spreads by extension of an amebic liver abscess and also spreads hematogenously, lymphogenously, and by inhalation of dust containing cysts and trophozoites of E. histolytica . In this case, we hypothesized that the intra-abdominal tumor developed by hematogenous spread from amebic colitis, although we could not pathologically confirm cysts or trophozoites in the small vessels or lymphatic vessels. If an intra-abdominal tumor was present and amebic colitis was observed, tumor related to E. histolytica would need to be considered among the differential diagnoses, and removal should be performed in such a manner as to avoid damaging the tumor.
In some reports and reviews, a typical treatment regimen for E. histolytica infection has been MTZ for 10–14 days (500–750 mg, three times/day) or tinidazole for 3 days (2 g/day), followed by a 7-day course of paromomycin (25–35 mg/kg daily in three divided doses) to eliminate colonization [13, 14, 19]. In contrast, Watanabe et al. reported that the cumulative probability of recurrent invasive amebic disease after MTZ or tinidazole treatment showed no significant difference with or without subsequent luminal treatment. Controversy remains regarding the need for cyst eradication using paromomycin following MTZ or tinidazole . Although we did not administer paromomycin after MTZ treatment and surgery in this case, no recurrence of symptoms due to E. histolytica has been seen to date.
No standard treatment strategy for amebic intra-abdominal tumor has yet been established. We might have achieved cure with MTZ treatment alone, using the treatment strategy for amebic liver abscess [13, 14, 22, 24, 25], but we considered complete resection of the tumor as prudent for this case in which definitive diagnosis had not been achieved. Either way, close attention must be paid to avoid bursting the cystic tumor at the time of extraction.
Intra-abdominal tumor may represent asymptomatic E. histolytica infection and warrants colonofiberscopy. When amebic colitis is observed, amebic intra-abdominal tumor should be considered as a differential diagnosis.
Written informed consent for publication of this case report and the accompanying images was obtained from the patient. A copy of the written consent is available for review by the Editor in Chief of this journal.
- Wuerz T, Kane JB, Boggild AK, Krajden S, Keystone JS, Fuksa M, et al. A review of amoebic liver abscess for clinicians in a nonendemic setting. Can J Gastroenterol. 2012;26(10):729–33.PubMed CentralPubMedGoogle Scholar
- Natarajan A, Souza RE, Lahoti NG, Candrakala SR. Ruptured liver abscess with fulminant amoebic colitis: case report with review. Trop Gastroenterol. 2000;21(4):201–3.PubMedGoogle Scholar
- Shamsuzzaman SM, Hashiguchi Y. Thoracic amebiasis. Clin Chest Med. 2002;23(2):479–92.PubMedView ArticleGoogle Scholar
- Lbarra PC. Thoracic complications of amebic abscess of the liver: report of 501 cases. Chest. 1981;79:672–7.View ArticleGoogle Scholar
- Chalhoub S, Kanafani Z. Entamoeba histolytica pleuropulmonary infection. Case report and review of the literature. J Med Liban. 2012;60(2):122–4.PubMedGoogle Scholar
- Miyauchi T, Takiya H, Sawamura T, Murakami E. Cardiac tamponade due to intrapericardial rupture of an amebic liver abscess. Jpn J Thorac Cardiovasc Surg. 2005;53(4):206–9.PubMedView ArticleGoogle Scholar
- Mondragón SR, Cortes ET, Sánchez CR, Parra SH, Hurtado AH. Rupture of an amebic liver abscess into the pericardium. Presentation of a case and review of current management. Hepatogastroenterology. 1994;41(6):585–8.Google Scholar
- Maldonado-Barrera CA, Campos-Esparza MR, Muñoz-Fernández L, Victoria-Hernández JA, Campos-Rodríguez R, Talamás-Rohana P. Clinical case of cerebral amebiasis caused by E. histolytica. Parasitol Res. 2012;110(3):1291–6.PubMedView ArticleGoogle Scholar
- Goh LM, Marrone JR. Entamoeba histolytica meningoencephalitis diagnosed by trophozoites in cerebrospinal fluid. New Microbes New Infect. 2013;1(1):16–7.PubMed CentralPubMedView ArticleGoogle Scholar
- Sundaram C, Prasad BC, Bhaskar G, Lakshmi V, Murthy JM. Brain abscess due to Entamoeba histolytica. J Assoc Physicians India. 2004;52:251–2.PubMedGoogle Scholar
- Parshad S, Grover PS, Sharma A, Verma DK, Sharma A. Primary cutaneous amoebiasis: case report with review of the literature. Int J Dermatol. 2002;41(10):676–80.PubMedView ArticleGoogle Scholar
- Ferrari Jr NM, Schmitz Jr R, Framil VM, Muller H, Chieffi PP. Epidermal cyst infected by Entamoeba histolytica in a patient with no past history of intestinal amebiasis. Int J Dermatol. 2010;49(12):1454–6.PubMedView ArticleGoogle Scholar
- Haque R, Huston CD, Hughes M, Houpt E, Petri Jr WA. Amebiasis. N Engl J Med. 2003;348(16):1565–73.PubMedView ArticleGoogle Scholar
- Stanley Jr SL. Amoebiasis. Lancet. 2003;361(9362):1025–34.PubMedView ArticleGoogle Scholar
- Tengku SA, Norhayati M. Public health and clinical importance of amoebiasis in Malaysia: a review. Trop Biomed. 2011;28(2):194–222.PubMedGoogle Scholar
- Ximénez C, Morán P, Rojas L, Valadez A, Gómez A. Reassessment of the epidemiology of amebiasis: state of the art. Infect Genet Evol. 2009;9(6):1023–32.PubMedView ArticleGoogle Scholar
- Leung PO, Chen KH, Chen KL, Tsai YT, Liu SY, Chen KT. Epidemiological features of intestinal infection with Entamoeba histolytica in Taiwan, 2002–2010. Travel Med Infect Dis. 2014;12(6 Pt A):673–9.PubMedView ArticleGoogle Scholar
- National Institute of Infectious Diseases. http://www.nih.go.jp/niid/ja/survei/2085-idwr/ydata/5195-report-ja2013-30.html.
- Skappak C, Akierman S, Belga S, Novak K, Chadee K, Urbanski SJ, et al. Invasive amoebiasis: a review of Entamoeba infections highlighted with case reports. Can J Gastroenterol Hepatol. 2014;28(7):355–9.PubMed CentralPubMedGoogle Scholar
- Yang DM, Jung DH, Kim H, Kang JH, Kim SH, Kim JH, et al. Retroperitoneal cystic masses: CT, clinical, and pathologic findings and literature review. Radiographics. 2004;24(5):1353–65.PubMedView ArticleGoogle Scholar
- Ogawa M, Iwamura H, Yamamura M. Case report of omental cyst (in Japanese). Shounika Rinshou (Pediatc Rinsho). 1983;36:1505–10.Google Scholar
- Salles JM, Moraes LA, Salles MC. Hepatic amebiasis. Braz J Infect Dis. 2003;7(2):96–110.PubMedView ArticleGoogle Scholar
- Watanabe K, Gatanaga H, Escueta-de Cadiz A, Tanuma J, Nozaki T, Oka S. Amebiasis in HIV-1-infected Japanese men: clinical features and response to therapy. PLoS Negl Trop Dis. 2011;5(9), e1318.PubMed CentralPubMedView ArticleGoogle Scholar
- Bammigatti C, Ramasubramanian NS, Kadhiravan T, Das AK. Percutaneous needle aspiration in uncomplicated amebic liver abscess: a randomized trial. Trop Doct. 2013;43(1):19–22.PubMedView ArticleGoogle Scholar
- Van Allan RJ, Katz MD, Johnson MB, Laine LA, Liu Y, Ralls PW. Uncomplicated amebic liver abscess: prospective evaluation of percutaneous therapeutic aspiration. Radiology. 1992;183(3):827–30.PubMedView ArticleGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.